Cargando…

Non-Lethal Endotoxin Injection: A Rat Model of Hypercoagulability

Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance fav...

Descripción completa

Detalles Bibliográficos
Autores principales: Brooks, Marjory B., Turk, James R., Guerrero, Abraham, Narayanan, Padma K., Nolan, John P., Besteman, Elizabeth G., Wilson, Dennis W., Thomas, Roberta A., Fishman, Cindy E., Thompson, Karol L., Ellinger-Ziegelbauer, Heidrun, Pierson, Jennifer B., Paulman, April, Chiang, Alan Y., Schultze, Albert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233421/
https://www.ncbi.nlm.nih.gov/pubmed/28081568
http://dx.doi.org/10.1371/journal.pone.0169976
Descripción
Sumario:Systemic inflammation co-activates coagulation, which unchecked culminates in a lethal syndrome of multi-organ microvascular thrombosis known as disseminated intravascular coagulation (DIC). We studied an endotoxin-induced inflammatory state in rats to identify biomarkers of hemostatic imbalance favoring hypercoagulability. Intraperitoneal injection of LPS at 15 mg/kg body weight resulted in peripheral leukopenia and widespread neutrophilic sequestration characteristic of an acute systemic inflammatory response. Early indicators of hemostatic pathway activation developed within 4 hours, including increased circulating concentrations of procoagulant extracellular vesicles (EVs), EVs expressing endothelial cell and platelet membrane markers, and high concentration of soluble intercellular adhesion molecule-1 (sICAM-1), plasminogen activator inhibitor-1 (PAI-1), and D-dimers. Inflammation persisted throughout the 48-hour observation period; however, increases were found in a subset of serum microRNA (miRNA) that coincided with gradual resolution of hemostatic protein abnormalities and reduction in EV counts. Dose-adjusted LPS treatment in rats provides a time-course model to develop biomarker profiles reflecting procoagulant imbalance and rebalance under inflammatory conditions.